ARYA Sciences Acquisition Corp IV financial data

Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q/A - Q1 2024 - 21 May 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2% % -43%
Debt-to-equity -102% % 0.87%
Return On Equity 20% %
Return On Assets -6% % -653%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $4,395,415 USD 155%
Operating Income (Loss) $4,395,415 USD -155%
Net Income (Loss) Attributable to Parent $2,539,431 USD -276%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current $140,904 USD 23%
Assets $37,260,800 USD -2.5%
Accounts Payable, Current $157,777 USD 129%
Accrued Liabilities, Current $8,602,809 USD 28%
Liabilities, Current $12,145,586 USD 59%
Liabilities $14,761,836 USD 44%
Retained Earnings (Accumulated Deficit) $15,039,010 USD -50%
Stockholders' Equity Attributable to Parent $14,520,932 USD -45%
Liabilities and Equity $37,260,800 USD -2.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $511,686 USD -142%
Net Cash Provided by (Used in) Financing Activities $3,388,804 USD 97%
Net Cash Provided by (Used in) Investing Activities $3,967,804 USD -97%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $87,505 USD 46%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Additional Paid in Capital $517,654 USD
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%